Novel Cancer Vaccine May Improve Survival in Synovial Sarcoma
Pharma & biotech2018-06-26
22 Views
Investigators are hopeful that CMB305, a vaccine that boosts the immune response to tumor cells expressing the antigen NY-ESO-1, can improve survival outcomes for patients with synovial sarcoma.
Source: OncLive
The news, reports, views and opinions of authors (or source) expressed are their own and do not necessarily represent the views of CRWE World.
NIO Inc. (NYSE: NIO) Provides November 2020 Delivery Update
